Filing Details
- Accession Number:
- 0001209191-15-086525
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-22 11:36:39
- Reporting Period:
- 2015-12-18
- Filing Date:
- 2015-12-22
- Accepted Time:
- 2015-12-22 11:36:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1008848 | Acorda Therapeutics Inc | ACOR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1272353 | David Lawrence | 420 Saw Mill River Road Ardsley NY 10502 | Chief Of Business Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-18 | 17,527 | $6.00 | 26,729 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-18 | 21,499 | $5.85 | 48,228 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-18 | 38,506 | $40.62 | 9,722 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-18 | 520 | $41.06 | 9,202 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-12-18 | 17,527 | $0.00 | 17,527 | $6.00 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-12-18 | 21,499 | $0.00 | 21,499 | $5.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-02-15 | No | 4 | M | Direct | |
| 0 | 2016-03-17 | No | 4 | M | Direct |
Footnotes
- Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2016 on the expiration date reported within Table II unless exercised.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $40.0400 to $41.0319 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $41.0500 to $41.0700 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The shares subject to these options vested in installments and were fully vested on February 15, 2010.
- The shares subject to these options vested in installments and were fully vested on February 10, 2010.
Billionaire Hedge Funds
